Dermatology Devices Market | Latest Trends |Oppertunities | In-depth Study with Global Key Players - Valeant Pharmaceuticals International Inc., Cynosure Inc., Lumenis, Syneron Candela Ltd., Avita Medical Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd.

Market Research Report Search Engine (MRRSE) recently announced the addition of a new research study to its comprehensive collection of research reports. The research report, titled “Dermatology Devices Market: Rising Demand for Non-invasive Dermatological Procedures Boosting Market Growth: Global Industry Analysis and Opportunity Assessment, 2016-2026” offers a detailed analysis of the market providing insights into the market dynamics that are expected to influence the overall market positively in the next few years. Furthermore, the product segmentation, drivers, barriers, key geographical segments, and the competitive scenario of the global Dermatology Devices Market have been elaborated upon in the research report.

Request Free Sample on Dermatology Devices Market Research Report @ https://www.mrrse.com/sample/2716

Dermatology devices comprise lasers, RF devices, microdermabrasion devices, and other related accessories. These devices are installed in hospitals and dermatology clinics to assist physicians and non-physician clinicians to treat skin diseases and are also used to diagnose skin cancer. In terms of revenue, the global dermatology devices market is projected to register a CAGR of 7.0% during the forecast period and is expected to be valued at US$ 5,307.6 Mn by the end of 2026.

Rising demand for non-invasive dermatological procedures and increasing aesthetic awareness are factors boosting the adoption of dermatology devices globally

Growth of the global dermatology devices market is primarily driven by increasing prevalence of skin problems including acne leading to scars, growing demand for at-home devices, and significant increase in non-invasive liposuction procedures along with a growing obese population. The global market for dermatology devices is expected to witness a significant growth rate in terms of value owing to an increasing aesthetic awareness, increasing fashion consciousness, and the growing demand for non-invasive cosmetic correction procedures. Moreover, growing healthcare expenditure, increasing geriatric population, and rising disposable income is creating high potential growth opportunities for players operating in the global dermatology devices market.

However, high costs of dermatological treatments, side effects related to dermatological treatments, and uncertainty related to U.S. Healthcare reforms might hinder market growth over the forecast period (2016 – 2026).

Lasers product type segment expected to dominate the market by 2016 end, due to an increasing application in cosmetic correction procedures

In terms of revenue share, the Lasers segment dominated the global dermatology devices market in 2015 and is expected to dominate throughout the forecast period, registering a higher CAGR over the forecast period. The RF Devices segment is expected to witness a CAGR of 6.6% in terms of value over the forecast period.       

Browse Complete Detail on Dermatology Devices Market Research Report with TOC @ https://www.mrrse.com/dermatology-devices-market     

Vascular Lesions application segment anticipated to hold high market share through 2026

The Vascular Lesions segment held maximum share in 2015 and is expected to continue its dominance throughout the forecast period. The Tattoo Removal segment is anticipated to reach US$ 943.9 Mn by 2026 owing to an increase in awareness among people regarding the health hazards caused by tattoo ink at later stages of life.

Specialty Dermatology Clinics end user segment has been growing owing to an increasing preference for specialists for cosmetic correction treatments

The Speciality Dermatology Clinics segment is estimated to account for 36.2% revenue share of the global dermatology devices market by 2016 end. Number of patients preferring private clinics over hospitals has been increasing over the years, as additional costs such as management costs are not associated with private clinics.

North America is expected to dominate the global market by 2016 end

The North America regional market is anticipated to account for 22.6% revenue share of the global dermatology devices market by 2016 end and is expected to gain in terms of market share due to increase in skin disorders, skin cancer, and a growing preference for cosmetic surgeries. In terms of value, Eastern Europe is expected to register the highest CAGR of 8.6% over the forecast period.

Dermatology devices manufacturers are likely to target APEJ and MEA markets through mergers with established local players in the laser and RF devices market to increase their customer base

Valeant Pharmaceuticals International Inc., Cynosure Inc., Lumenis, Syneron Candela Ltd., Avita Medical Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., Cutera, Lutronics Corporation, and Beijing Toplaser Technology Co. Ltd. are some of the top companies operating in the global dermatology devices market.
Inquire More about This Report @ https://www.mrrse.com/enquiry/2716

About (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us                            

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/

This release was published on openPR.